Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Good Manufacturing Practices: FDA’s 21st Century Quality Initiative Turns From Concept To Implementation

Executive Summary

The pharmaceutical industry is welcoming FDA's move toward greater flexibility in quality control inspections and manufacturing changes for firms with good quality systems but seeks more concrete information on how flexibility will be achieved in practice

You may also be interested in...



A Closer Look: Supplement GMPs May Offer Insights For Drug GMPs

FDA's approach to good manufacturing practices has been moving toward a focus on testing input materials and manufacturing processes rather than solely on testing end products - an evolution reflected most recently in the Center for Food Safety and Applied Nutrition's new rules on dietary supplement GMPs

A Closer Look: Supplement GMPs May Offer Insights For Drug GMPs

FDA's approach to good manufacturing practices has been moving toward a focus on testing input materials and manufacturing processes rather than solely on testing end products - an evolution reflected most recently in the Center for Food Safety and Applied Nutrition's new rules on dietary supplement GMPs

PET Drugs Draft Rule Relaxes Proposed GMP Requirements After Comments

FDA's latest proposed rule on current good manufacturing practices for positron emission tomography products drops several requirements that had been included in previous iterations of the reg

Related Content

UsernamePublicRestriction

Register

PS045163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel